11.
    发明专利
    未知

    公开(公告)号:ES2082777T3

    公开(公告)日:1996-04-01

    申请号:ES89307202

    申请日:1989-07-14

    Applicant: IDEXX LAB INC

    Abstract: A method for detecting the presence of antibody to FIV in a biological sample. The method includes the steps of providing a first antigen having a first epitope recognized by the antibody, the first antigen being detectable; contacting the first antigen with the sample under conditions under which the antibody can bind to the first antigen to form an immune complex; and detecting the immune complex. An ELISA test for FIV, using purified FIV antigen, is also described.

    12.
    发明专利
    未知

    公开(公告)号:DE69909897T2

    公开(公告)日:2004-05-27

    申请号:DE69909897

    申请日:1999-05-14

    Applicant: IDEXX LAB INC

    Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods.

    14.
    发明专利
    未知

    公开(公告)号:AT130681T

    公开(公告)日:1995-12-15

    申请号:AT89307202

    申请日:1989-07-14

    Applicant: IDEXX LAB INC

    Abstract: A method for detecting the presence of antibody to FIV in a biological sample. The method includes the steps of providing a first antigen having a first epitope recognized by the antibody, the first antigen being detectable; contacting the first antigen with the sample under conditions under which the antibody can bind to the first antigen to form an immune complex; and detecting the immune complex. An ELISA test for FIV, using purified FIV antigen, is also described.

    DETECTION OF AN ANTIBODY AND ANTIGEN IN AN IMMUNOASSAY

    公开(公告)号:CA1335880C

    公开(公告)日:1995-06-13

    申请号:CA605599

    申请日:1989-07-13

    Applicant: IDEXX LAB INC

    Abstract: A method for detecting the presence of antibody to FIV in a biological sample. The method includes the steps of providing a first antigen having a first epitope recognized by the antibody, the first antigen being detectable; contacting the first antigen with the sample under conditions under which the antibody can bind to the first antigen to form an immune complex; and detecting the immune complex. An ELISA test for FIV, using purified FIV antigen, is also described.

Patent Agency Ranking